Why is Allarity Therapeutics Stock Trading Higher Today?
Portfolio Pulse from Vandana Singh
Allarity Therapeutics Inc (NASDAQ:ALLR) and Detsamma Investments Pty Ltd have entered a Clinical Collaboration Agreement. Under this agreement, Allarity will support FivepHusion's future clinical development of Deflexifol for solid tumors. FivepHusion will receive a first option to negotiate and obtain from Allarity a global, exclusive license to use and commercialize the DRP-5FU CDx through Phase 3 registration trials, regulatory approval, and market. Financial terms of the collaboration are not disclosed.
July 31, 2023 | 3:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Allarity Therapeutics has entered a Clinical Collaboration Agreement with Detsamma Investments. This could potentially lead to milestone payments for Allarity if FivepHusion exercises its option right and receives a license to the Allarity DRP companion diagnostic technology related to Deflexifol.
The news of the Clinical Collaboration Agreement between Allarity Therapeutics and Detsamma Investments is directly related to Allarity and its future revenues. If FivepHusion exercises its option right and receives a license to the Allarity DRP companion diagnostic technology related to Deflexifol, Allarity will receive certain milestone payments. This could potentially increase Allarity's revenues and positively impact its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100